Accord Healthcare

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to over 70 markets around the world.
 

DRUG REACTION REPORT

report

01

TRULY MULTINATIONAL

Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products in over 35 European countries.

02

A COMPLETE APPROACH

Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.

GROWTH’S IN OUR NATURE

Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK & Ireland.

Acquiring Actavis UK and Ireland in 2017 facilitates Accord’s ambition of becoming a top 5 pan-EMENA generics company by 2021 and to have developed a specialty products commercialisation capability.

03

European Focus

Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
 

04

News

24-07-2017

ACCORD HEALTHCARE UK LAUNCHES DUTASTERIDE CAPSULES ON DAY ONE OF PATENT EXPIRY

Following the patent expiry on 18th July, Accord UK is pleased to announce the launch of Dutasteride 0.5mg Soft Capsules. This product launch further strengthens the expanding Accord UK portfolio.

24-07-2017

DAY ONE LAUNCH FOR ACCORD HEALTHCARE

Accord Healthcare UK has launched Etoricoxib 30mg, 60mg, 90mg & 120mg Tablets on day one of patent expiry.